Literature DB >> 20049862

Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis.

Jose Luis Luque-García1, Jorge Luis Martínez-Torrecuadrada, Carolina Epifano, Marta Cañamero, Ingrid Babel, J Ignacio Casal.   

Abstract

Progression to metastasis is the critical point in colorectal cancer (CRC) survival. However, the proteome associated to CRC metastasis is very poorly understood at the moment. In this study, we used stable isotope labeling by amino acids in cell culture to compare two CRC cell lines: KM12C and KM12SM, representing poorly versus highly metastatic potential, to find and quantify the differences in protein expression, mostly at the cell surface level. After biotinylation followed by affinity purification, membrane proteins were separated by SDS-PAGE and analyzed using nanoflow LC-ESI-LTQ. A total of 291 membrane and membrane-associated proteins were identified with a p value<0.01, from which 60 proteins were found to be differentially expressed by more than 1.5-fold. We identified a number of cell signaling, CDs, integrins and other cell adhesion molecules (cadherin 17, junction plakoglobin (JUP)) among the most deregulated proteins. They were validated by Western blot, confocal microscopy and flow cytometry analysis. Immunohistochemical analysis of paired tumoral samples confirmed that these differentially expressed proteins were also altered in human tumoral tissues. A good correlation with a major abundance in late tumor stages was observed for JUP and 17-beta-hydroxysteroid dehydrogenase type 8 (HSD17B8). Moreover, the combined increase in JUP, occludin and F11 receptor expression together with cadherin 17 expression could suggest a reversion to a more epithelial phenotype in highly metastatic cells. Relevant changes were observed also at the metabolic level in the pentose phosphate pathway and several amino acid transporters. In summary, the identified proteins provide us with a better understanding of the events involved in liver colonization and CRC metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049862     DOI: 10.1002/pmic.200900441

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  30 in total

Review 1.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

2.  Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma.

Authors:  Changchuan Pan; Yalan Tao; Ming Zhao; Wang Li; Zilin Huang; Jing Gao; Yanhen Wu; Jingrui Yu; Peihong Wu; Yunfei Xia; Jin Lu
Journal:  Exp Ther Med       Date:  2012-03-23       Impact factor: 2.447

3.  Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

Authors:  Yekaterina Y Zaytseva; Piotr G Rychahou; Pat Gulhati; Victoria A Elliott; William C Mustain; Kathleen O'Connor; Andrew J Morris; Manjula Sunkara; Heidi L Weiss; Eun Y Lee; B Mark Evers
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

Review 4.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

5.  Single reporter for targeted multimodal in vivo imaging.

Authors:  Johanna M Niers; John W Chen; Grant Lewandrowski; Mariam Kerami; Elisabeth Garanger; Greg Wojtkiewicz; Peter Waterman; Edmund Keliher; Ralph Weissleder; Bakhos A Tannous
Journal:  J Am Chem Soc       Date:  2012-03-07       Impact factor: 15.419

6.  An RGD motif present in cadherin 17 induces integrin activation and tumor growth.

Authors:  Rubén A Bartolomé; Alberto Peláez-García; Inmaculada Gomez; Sofía Torres; María Jesús Fernandez-Aceñero; Beatriz Escudero-Paniagua; J Ignacio Imbaud; J Ignacio Casal
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

7.  Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.

Authors:  Akiko Hanyuda; Yin Cao; Tsuyoshi Hamada; Jonathan A Nowak; Zhi Rong Qian; Yohei Masugi; Annacarolina da Silva; Li Liu; Keisuke Kosumi; Thing Rinda Soong; Iny Jhun; Kana Wu; Xuehong Zhang; Mingyang Song; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Reiko Nishihara
Journal:  Eur J Epidemiol       Date:  2017-05-16       Impact factor: 8.082

8.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

9.  Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.

Authors:  Christopher J Hayes; Catriona M Dowling; Susan Dwane; Mary E McCumiskey; Shona M Tormey; B Anne Merrigan; John C Coffey; Patrick A Kiely; Tara M Dalton
Journal:  Biomicrofluidics       Date:  2016-10-31       Impact factor: 2.800

Review 10.  Proteomics for discovery of candidate colorectal cancer biomarkers.

Authors:  Paula Alvarez-Chaver; Olalla Otero-Estévez; María Páez de la Cadena; Francisco J Rodríguez-Berrocal; Vicenta S Martínez-Zorzano
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.